Nasal Drug Delivery Technology Market Report Analysis

1
Nasal Drug Delivery Technology Market Trend
Report and Industry Analysis on Nasal Drug
Delivery Technology Market
2
Business Strategies and Consultant
3
Table Of Contents
Business Introduction
Report Segmentation
Market Introduction
Research Methodology
Primary Respondent
Our Services
Continent Breakdown
Contact Us
4
Our Company
Delvens is a market research and consulting
company headquartered in Delhi, India. The
company holds expertise in providing syndicated
research reports, customized research reports,
and consulting services. Delvens qualitative and
quantitative data is highly utilized by each
level from niche markets to major markets,
serving more than 800 prominent companies by
assuring to provide the information on country,
regional, and global business environment. We
have a database for more than 45 industries in
more than 50 major countries globally.
5
Nasal Drug Delivery Technology Market
An Introduction to the Nasal Drug Delivery
Technology
6
Introduction

• Drugs enter the systemic circulation via a
  variety of routes, including oral, parenteral
  (intravenous, intramuscular), and intramuscular
  administration. In most cases, drugs administered
  via these routes undergo acidic or enzymatic
  degradation and may experience an excessive
  first-pass effect (hepatic metabolism) following
  administration. Because of these characteristics,
  appropriate pharmacological dosages may not
  always reach the systemic circulation, resulting
  in inefficient therapy. As a result, it is
  necessary to investigate alternative routes or
  specialized delivery technologies that can result
  in enhanced and effective medication delivery
  solutions. The nasal route of drug administration
  is one such alternative route that allows access
  to highly vascularized mucosa, which can be used
  as an intriguing site for local, systemic, and
  targeted drug delivery (CNS).

7
Market Prospect

• The worldwide nasal medication delivery
  technology market is expected to be worth USD
  64.20 billion by 2021, growing at a 6.5 percent
  CAGR during the forecast period.
• North America dominated the market with a revenue
  share of 36.21 percent in 2017. This growth was
  connected to an increase in sickness prevalence
  as well as consumer awareness of nasal products.
  According to the CDC, about 20.4 million people
  in the United States aged 18 and above had asthma
  in 2017, accounting for around 8.3 percent of the
  total population. Furthermore, around 6.1 million
  children under the age of 18 have asthma. The
  established economies of North America will fuel
  significant development in the next years.
• Asia Pacific is expected to have the fastest CAGR
  of 7.5 percent in the next years. This growth is
  mostly due to the availability of effective
  treatment processes, considerable unmet clinical
  demands, growing disposable income levels, and
  improved consumer

8

• awareness of these products. Furthermore, the
  presence of key companies in this space, such as
  Aptar Group, Inc., Sun Pharmaceutical Industries
  Ltd., and Cipla Inc., is expected to assist the
  industry as a whole.
• Europe is the second largest market for nasal
  medicine delivery technology, owing to increased
  RD activities and rising cigarette consumption.
  According to the World Health Organization,
  Europe has the highest incidence of adult tobacco
  use (28) and some of the highest rates of
  adolescent tobacco use.

9
Market Drivers
According to a nasal drug delivery technology
report analysis, some of the primary factors
driving the growth of the nasal drug delivery
technology market include rising patient
preference for nasal medication delivery due to
ease of administration and improved efficacy, an
increase in the incidence of chronic diseases,
and increased acceptance of self-administration
practices. One of the most common drug delivery
strategies among both consumers and healthcare
practitioners is intranasal medication
administration. This is mostly owing to the
non-invasive nature of the nasal route and the
fact that medicine absorbability is higher via
the nasal route. Companies have used new
technology to create products that are compact,
portable, and simple to use. Because it enables a
speedier onset of action for the treatment of
associated disorders, the nasal route has been
regarded acceptable for pharmaceutical
administration.
10

• Over the forecast period, the concerns related
  with nasal spray overuse are projected to impede
  the growth of the nasal medicine delivery
  technology market. Regulatory barriers may limit
  the growth of the nasal medicine delivery
  technology market in the near future.
• The COVID-19 pandemic benefitted the nasal drug
  delivery industry by increasing the use of
  inhalers at home rather than in hospitals or
  outpatient clinics since many patients chose to
  do their chronic respiratory ailment medication
  therapy at home. Nasal inhalers are increasingly
  being used to treat asthma, migraines, and other
  mental illnesses. Furthermore, a number of
  pharmaceutical companies have begun to develop
  vaccines that use nasal drug delivery technology,
  with some of them currently in clinical studies.

11
Recent Development

• In 2020, the European Joint Programme on Rare
  Diseases issued a request for firms to address
  four obstacles. One of the tasks, sponsored by
  the Italian pharmaceutical company Chiesi, was to
  design a delivery device for intranasal
  administration of biological medicines to
  newborns.
• Eli Lilly recognised 3D printing as a means to
  deliver medications to particular sections of the
  gastrointestinal system, prompting the company to
  collaborate with Triastek on the targeted release
  of molecules in the gut.

12
Conclusions
Factors such as rising patient preference for
nasal medication and increased acceptance of
self-administration has helped in gaining the
popularity for nasal drugs. Also pandemic has
helped in rising the market of nasal drug.
However, concerns related to nasal spray overuse
has led the regulatory authorities to limit its
use but with new research and development, this
technology may overcome this barrier.
13
Designation Breakdown
Breakdown of our data collection from People of
different Designation
14
Product Manager
Primary Respondent
CEO
They are the major contributor with 35
30 of our primary respondents
Sales Manager
Distributors
Their contribution is about 25
10 of our data come from them
15
Continent Breakdown

• Breakdown of our data collection from different
  continents

16
(No Transcript)
17
Report Segmentation
Containers
Therapeutic Application
Region
Systems
Dosage Form
End-User
18

• On the basis of Dosage Form
• Nasal Spray
• Nasal Drops Liquids
• Nasal Gel
• Nasal Powder
• On the basis of Container
• Non-pressurized Container
• Pressurized Container
• On the basis of system
• Multi-dose
• Bi-dose
• Unit Dose

19

• On the basis of Therapeutic Application
• Allergic and Non-Allergic Rhinitis
• Nasal Congestion
• Vaccination
• On the basis of End-User
• Hospital
• Home Healthcare

20

• On the basis of Region
• North America
• South America
• Asia Pacific
• Europe
• Middle East Africa

21
How to Purchase the Report

• Delvens offers many customisation to cater your
  need. Our popular customisation is that our
  report is segmented as per user where you got
  option to choose from
• Single User
• Multiple User
• Corporate User
• If you want report for Globally, Regional or
  Country specific, then voila, we also provide an
  easy step to choose from continent-wise as well
  as country-wise report. If you have any special
  requirement or you want more customization, you
  can contact our customer representative who are
  24X7 available for you.
• You can talk to our representative by clicking

Contact Us
22
No. Of Pages 376
Report Global
Report Regional
Report Country Specific
User Single
User Multi
User Corporate
Get latest and trending updates throughout the
year on the reports you buy.
23
Research Methodology
Market Integration
Data Extraction
Data Analysis
Data Validation
24
Data Extraction The stage involves the
procurement of market data or related information
via different sources methodologies. Data
Analysis This step involves the analysis
mapping of all the information procured from the
previous step. It also encompasses the analysis
of data discrepancies observed across various
data sources. Market Integration The final step
entails the placement of data points at
appropriate market spaces in an attempt to deduce
viable conclusions. Analyst perspective subject
matter expert based heuristic form of market
sizing also plays an integral role in this
step. Data Validation Validation is the most
important step in the process. Validation
re-validation via an intricately designed process
helps us finalize data-points to be used for
final calculations.
25
Our Services
2
Best Practice Guide
1
Syndicated Research
4
Consulting Services
3
Custom Research Services
6
Audio-Video Infographic Workshop
3
5
Implementation Support
3
8
Bundle Reports Model
1
7
Subscription Model
1
26
Thank You